Cardinal Health to Buy J&J's Heart Business for $1.94 Billion

Related Link: 

Cardinal Health agreed to acquire the heart-product business Cordis from Johnson & Johnson for $1.94 billion in cash, in a move aimed at strengthening its cardiology efforts.

Swiss Companies Battle Strong Franc

Related Link: 

Tiny plastics company Scheu is one of a growing number of Swiss businesses that are exploring extraordinary measures to combat the local currency’s surging value.

Gannett Settles With Icahn

Related Link: 

Gannett Co. has agreed to implement certain corporate-governance policies at the upcoming spinoff of its publishing division, settling a dispute with activist investor Carl Icahn.

Sotheby's Earnings Fall as Expenses Grow

Related Link: 

Sotheby’s posted an 18.5% drop in earnings due to higher expenses, as the auction house faces pressure from shareholders and searches for a new chief executive.

Vodafone to Launch U.K. TV Services

Related Link: 

Vodafone will launch television services later this year as the wireless telecoms operator tries to boost revenues amid greater competition from incumbent players.

HTC Enters Virtual-Reality Market---Mobile World

Related Link: 

Taiwanese smartphone maker HTC Corp. is entering the world of virtual reality, part of its move to diversify its product line to boost sales.

Endo to Sell Men's Health Businesses to Boston Scientific

Related Link: 

Endo International PLC said Monday that it has agreed to sell its men’s health and prostate businesses to Boston Scientific for $1.6 billion, in a bid to streamline and focus instead on its core pharmaceuticals business.

Abertis Buys Majority Stake in Wind's Telecom Tower Unit

Related Link: 

Spain’s Abertis Infraestructuras said it has agreed to buy 90% of the telecommunication tower business of Italy’s Wind Telecomunicazioni.

Glencore Faces Hit From Big Coal Bet

Related Link: 

Investors will get their first look on Tuesday at a full year of Glencore’s financial results since it acquired Xstrata and its ample coal reserves in 2013. Coal prices are off about 25% since then.

Fujifilm Drug Draws Interest in Ebola Battle

Related Link: 

Fujifilm’s drug Avigan, which has shown signs of efficacy against the Ebola virus, has drawn interest from about 20 countries and the company stands ready for large orders, its chief executive said.

Syndicate content